Conflicting SS-31 schedules should not be resolved by averaging the numbers or choosing the most repeated recommendation. Different discussions may concern different products, diagnoses, goals and sources of information. Some provide no clinical evidence at all.
A regimen is tied to a clinical question
An approved medicine's instructions apply to the defined product and clinical circumstances addressed by its label. The Forzinity prescribing information is not a universal SS-31 wellness protocol.
Likewise, a trial schedule is part of an experiment. It does not become a validated regimen for other people simply because participants received it under supervision. Eligibility, monitoring, formulation and predefined outcomes are all part of the evidence.
Cycles add questions rather than settle them
A proposal to alternate exposure and breaks requires evidence for that pattern. How was the duration selected? Was intermittent use compared with another schedule? Were effects and adverse events measured after stopping? Did the tested preparation match the one under discussion?
The Barth trial described by the FDA included randomized and longer extension phases. That study structure does not establish that an internet-defined cycle produces lasting energy benefits in a different population.
A vial's price or total contents also cannot determine the medically appropriate duration. Making a purchase last longer and establishing a favorable benefit-risk balance are separate problems.
What to do with conflicting instructions
For a prescribed medicine, ask the prescriber and dispensing pharmacist to reconcile any uncertainty using the current product information. Include kidney problems, prior reactions and other medicines in that discussion because a clinical assessment is more than a calculation.
For research-only material, a calculator cannot supply the missing clinical validation. This article does not provide a starting amount, injection schedule, cycle length or conversion from trial exposure.
The useful conclusion is not that one forum schedule wins. It is that the proposed regimen must be supported for the exact product, population and purpose before its numbers can be treated as medical instructions.